• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . A Case of Severe Acute Respiratory Syndrome Coronavirus 2 Treatment With Remdesivir in a Hepatitis C-Coinfected Patient Res

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2021 Mar 2;8(4):ofab100.
doi: 10.1093/ofid/ofab100. eCollection 2021 Apr.
A Case of Severe Acute Respiratory Syndrome Coronavirus 2 Treatment With Remdesivir in a Hepatitis C-Coinfected Patient Resulting in Temporary Viral Control and Posttreatment Flare


Maria Ribeiro da Cunha[SUP] 1 [/SUP], In?s Coelho Rodrigues[SUP] 2 [/SUP], Frederico Trigueiros[SUP] 3 [/SUP], Lu?s Carlos Freitas[SUP] 2 [/SUP], Sandra Braz[SUP] 3 [/SUP], F?bio Cota Medeiros[SUP] 1 [/SUP]



Affiliations

Abstract

We report a case of a man with chronic hepatitis C infection treated with remdesivir for COVID-19, resulting in lowered HCV viral load, followed by a rebound after its discontinuation. Concomitant treatment with tocilizumab possibly caused loss of anti-HBs.

Keywords: COVID-19; anti-HBs; hepatitis B; hepatitis C; remdesivir.
 
Back
Top Bottom